Inhibition of human immunodeficiency virus type 1 replication is enhanced by a combination of transdominant Tat and Rev proteins
- PMID: 8676525
- PMCID: PMC190435
- DOI: 10.1128/JVI.70.7.4871-4876.1996
Inhibition of human immunodeficiency virus type 1 replication is enhanced by a combination of transdominant Tat and Rev proteins
Abstract
Mutation of either of two critical human immunodeficiency virus type 1 (HIV-1) regulatory proteins, Tat and Rev, results in marked defects in viral replication. Thus, inhibition of the function of one or both of these proteins can significantly inhibit viral growth. In the present study, we constructed a novel transdominant Tat mutant protein and compared its efficiency in inhibiting HIV-1 replication with that of transdominant mutant Rev M10 when these proteins were stably expressed either alone or in combination in T-lymphocyte cell lines. The transdominant Tat mutant protein alone resulted in a modest inhibition of HIV replication, but it was able to enhance the ability of the M10 Rev mutant protein to inhibit HIV-1 replication. These results suggest a possible synergistic effect of these transdominant mutant proteins in inhibiting HIV-1 replication.
Similar articles
-
Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication.J Exp Med. 1992 Oct 1;176(4):1197-201. doi: 10.1084/jem.176.4.1197. J Exp Med. 1992. PMID: 1402661 Free PMC article.
-
Inhibition of HIV-1 by a double transdominant fusion gene.Gene Ther. 1995 May;2(3):181-6. Gene Ther. 1995. PMID: 7614248
-
Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.J Virol. 2001 Apr;75(8):3590-9. doi: 10.1128/JVI.75.8.3590-3599.2001. J Virol. 2001. PMID: 11264348 Free PMC article.
-
Controlling elements in replication of the human immunodeficiency virus type 1.Cell Mol Biol (Noisy-le-grand). 1997 May;43(3):443-54. Cell Mol Biol (Noisy-le-grand). 1997. PMID: 9193800 Review.
-
Tat and Rev: positive modulators of human immunodeficiency virus gene expression.Gene Expr. 1991 May;1(2):85-90. Gene Expr. 1991. PMID: 1820213 Free PMC article. Review. No abstract available.
Cited by
-
Nullbasic, a potent anti-HIV tat mutant, induces CRM1-dependent disruption of HIV rev trafficking.PLoS One. 2012;7(12):e51466. doi: 10.1371/journal.pone.0051466. Epub 2012 Dec 10. PLoS One. 2012. PMID: 23251541 Free PMC article.
-
Differential Effects of Strategies to Improve the Transduction Efficiency of Lentiviral Vector that Conveys an Anti-HIV Protein, Nullbasic, in Human T Cells.Virol Sin. 2018 Apr;33(2):142-152. doi: 10.1007/s12250-018-0004-7. Epub 2018 Mar 14. Virol Sin. 2018. PMID: 29541943 Free PMC article.
-
Potent inhibition of HIV-1 replication by a Tat mutant.PLoS One. 2009 Nov 10;4(11):e7769. doi: 10.1371/journal.pone.0007769. PLoS One. 2009. PMID: 19901984 Free PMC article.
-
Functional domains of Tat required for efficient human immunodeficiency virus type 1 reverse transcription.J Virol. 1999 Mar;73(3):2499-508. doi: 10.1128/JVI.73.3.2499-2508.1999. J Virol. 1999. PMID: 9971835 Free PMC article.
-
Shutdown of HIV-1 Transcription in T Cells by Nullbasic, a Mutant Tat Protein.mBio. 2016 Jul 5;7(4):e00518-16. doi: 10.1128/mBio.00518-16. mBio. 2016. PMID: 27381288 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources